ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2463

Soluble Low-Density Lipoprotein Receptor-Related Protein 1 in Juvenile Idiopathic Arthritis

Alan M. Rosenberg1, Marianna Newkirk2, Elham Rezaei1, Zhenhong Li3 and Kiem Oen4, 1Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, 2Medicine, McGill University Health Centr, Montreal, QC, Canada, 3McGill University Health Centr, Montreal, QC, Canada, 4University of Manitoba, Winnipeg, MB, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Biomarkers, inflammation and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Pediatric Rheumatology - Pathogenesis and Genetics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Low-density lipoprotein receptor–related protein 1 (LRP1), a transmembrane protein, mediates endocytosis of an array of extracellular ligands.  LRP1 has intracellular and extracellular domains. With inflammation the extracellular domain can shed into the circulation as soluble LRP1 (sLRP1).  Increased sLRP1 has been reported in adult rheumatoid arthritis but not in childhood arthritis.  This study aimed to determine, in children with juvenile idiopathic arthritis (JIA), levels of sLRP1 and correlations with age, clinical indicators of disease activity, and inflammatory biomarkers.  

Methods: 111 newly diagnosed, treatment naïve children with JIA from 11 Canadian pediatric rheumatology centers were studied.  Plasma was assayed for sLRP1 by ELISA and for 47 inflammation-related biomarkers by bead-based, multiplex immunoassays.  Pearson correlations identified relationships between sLRP1 levels and indicators of disease activity and logarithmic transformed multiplex biomarker levels.  Differences in mean sLRP1 levels in relation to presence/absence of morning stiffness were analyzed by t-tests.  Comparison of sLRP1 means across JIA categories was assessed by ANOVA.    

Results:  Mean sLRP1 levels were highest in rheumatoid factor negative (RF-) polyarticular, oligoarticular, and psoriatic JIA and lowest in systemic JIA (Table). 

JIA Subtype (n)

Mean sLRP1 + 1 SD (ng/ml)

 RF– Polyarticular (41)

166.92 + 402.74

 Psoriatic (9)

136.34 + 161.16

 Oligoarticular (27)

120.51 + 156.97

 RF+ Polyarticular (8)

67.69 + 132.77

 Undifferentiated (4)

43.94 + 38.76

 Enthesitis Related (8)

33.40 + 29.72

 Systemic (14)

30.01 +14.48

ANOVA did not show significant mean sLRP1 differences among JIA subtypes.  Groups of children stratified as < age 4 years and < age 5 years had higher levels of sLRP1 than older children (p=0.019 and 0.028 respectively). sLRP1 levels did not correlate with active joint count, presence of morning stiffness, ESR, or CRP. In oligoarticular and RF- polyarticular JIA levels of sLRP1 were positively correlated with the same 32 biomarkers encompassing a wide array of pro- and anti-inflammatory cytokines, chemokines,  matrix metalloproteinases, and growth factors (p=0.026 to <0.001).  An additional 2 correlations with biomarkers were found in RF- polyarticular JIA. In contrast, sLRP1 levels correlated with only a small number of the 47  biomarkers in other JIA subtypes (9 in psoriatic ,  4 in RF+ polyarticular, 2 in enthesitis related arthritis, and none in systemic).

Conclusion:  In this first report of sLRP1 in JIA we found correlations of sLRP1 with young age and, in oligoarticular and RF-  polyarticular subtypes, with inflammation-related biomarkers. Findings suggest that oligoarticular and RF- polyarticular JIA are linked pathobiologically with respect to sLRP1 and the profile of biomarkers with which it is associated. Plasma sLRP1 could be a valuable biomarker reflective of inflammatory-mediated processes related to JIA subtype and onset age.


Disclosure: A. M. Rosenberg, None; M. Newkirk, None; E. Rezaei, None; Z. Li, None; K. Oen, None.

To cite this abstract in AMA style:

Rosenberg AM, Newkirk M, Rezaei E, Li Z, Oen K. Soluble Low-Density Lipoprotein Receptor-Related Protein 1 in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/soluble-low-density-lipoprotein-receptor-related-protein-1-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/soluble-low-density-lipoprotein-receptor-related-protein-1-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology